Michael McHeyzer-Williams, PhD

The Scripps Research Institute
La Jolla, CA
USA
Biographical Sketch: Dr. McHeyzer-Williams is a Professor in the Department of Immunology and Microbial Science at The Scripps Research Institute in La Jolla, California. He is a leading investigator in the field of immune memory and co-discoverer of the peptide/MHC tetramer technology that is now widely used to study immune responses in vivo. His research focuses on the cellular and molecular mechanisms controlling follicular helper T cell regulated development of antigen-specific B memory. Recent findings from Dr. McHeyzer-Williams' laboratory use high-order multidimensional single cell strategies to the analyze B cell memory at antigen recall. These studies provide new insight into the cellular organization and molecular control of adaptive immunity that are central to long-term immune protection with implications for contemporary vaccine design.

Any personal financial relationships? No

1. I will insure balance, independence, objectivity, and scientific rigor in my role in the planning, development or presentation of this CME activity.

2. I will comply with the requirements to protect health information under the Health Insurance Portability & Accountability Act of 1996 (HIPAA).

3. I will disclose any discussion or reference to unapproved or unlabeled uses of therapeutic agents or products.

4. I have input my full name below as attestation of agreement with declaration statements. Marking the check box and indicating my name is in lieu of signature and is considered an "e-signature".

Signed on 02/17/2015 by Michael McHeyzer-Williams

Papers:
Molecular Dynamics of Memory: A Single Cell Perspective

	1. I will insure balance, independence, objectivity, and scientific rigor in my role in the planning, development or presentation of this CME activity.
	2. I will comply with the requirements to protect health information under the Health Insurance Portability & Accountability Act of 1996 (HIPAA).
	3. I will disclose any discussion or reference to unapproved or unlabeled uses of therapeutic agents or products.
	4. I have input my full name below as attestation of agreement with declaration statements. Marking the check box and indicating my name is in lieu of signature and is considered an "e-signature".